Skip to content

SIMORQ

Active
Private limited companyfounded 20224 yrs activeMolenstraat 82, 3600 Genk, BelgiumKBO/BCE: BE 0786.684.846

SIMORQ has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-1k) and a net result of €-2k. Equity is shrinking by ~174.2% per year across the filed fiscal years. Its solvency ranks better than 5% of 17007 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).

Checked score

Score 2025
33 / 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-33
Solvency0▼-26
Growth32▼-26
Track record94
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 62
Relative position
BE, all sectors
reference
Sector 62
lower
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Age of the figures
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
232425
2023 to 2025 · latest year €-1k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
60 d early
2024
75 d early
2023
79 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€-1k
2024 · €1k
2023: €3k 2024: €1k
2023 → 2025
Total assets
€44▼ 100.0%
2024 · €101k
2023: €3k 2024: €101k
2023 → 2025
Net result
€-2k▼ 17.8%
2024 · €-2k
2023: €-2k 2024: €-2k
2023 → 2025
Working capital
€-1k
2024 · €1k
2024: €1k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€3k-€1k▼ 64.4%€-1k
Operating result€-2k-€-2k▲ 3.4%€-2k▼ 17.4%
Net result€-2k-€-2k▲ 3.8%€-2k▼ 17.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-3k€-2k€-1k€0Operating result 2023: €-2k€-2kNet result 2023: €-2k€-2kOperating result 2024: €-2k€-2kNet result 2024: €-2k€-2kOperating result 2025: €-2k€-2kNet result 2025: €-2k€-2k202320242025
The operating result stays negative: a loss of €2k in 2025 against €2k in 2024; the loss grows and 2025 has the lowest result in the available series.
Key figures and ratios
2025 value · change against 2024
Debt
€1k
2024 · €100k
Debt ≤ 1 year
€1k
2024 · €100k
Ratios withheld: a balance sheet total of €44 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€101k€44
Current assets29/58€101k€44
Cash at bank and in hand54/58€101k€44
Equity and liabilities
Total equity and liabilities10/49€101k€44
Equity10/15€1k€-1k
Contributions10/11€5k€5k=
Outside capital11€5k-
Other1109/19€5k-
Profit (loss) carried forward14€-4k€-6k
Amounts payable17/49€100k€1k
Amounts payable within one year42/48€100k€1k
Trade debts44-€1k
Suppliers440/4-€1k
Other amounts payable47/48€100k-
Income statement Code20242025
Other operating charges640/8€449€587
Gross operating margin9900€-1k€-2k
Operating profit (loss)9901€-2k€-2k
Financial income75/76B€2-
Recurring financial income75€2-
Financial charges65/66B€35€46
Recurring financial charges65€35€46
Profit (loss) for the period before taxes9903€-2k€-2k
Profit (loss) for the period9904€-2k€-2k
Profit (loss) for the period to be appropriated9905€-2k€-2k
Appropriation of the result
Profit (loss) to be appropriated9906€-4k€-6k
Profit (loss) brought forward from the previous period14P€-2k€-4k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
01-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Weakest financial yearnet €-2k
Net result drops to €-2k, the lowest in the series.
17-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
13-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Molenstraat 823600 Genk
Ground area
3,703 m²
Building footprint
310 m²
Volume, LiDAR
2,633 m³
Parcel 71016I1344/00D000, Flanders · tallest building 20.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BIOMEDIC PHARMA
Molenstraat 82, 3600 GenkOther software publishing
since 20222.346.663.392
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71016I1344/00D000 Flanders 3,703 m² 1 · 310 m² 20.1 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,886 companies in sector 62100 we hold annual accounts for 8,776. 998 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded31-05-2022
Fiscal year end31-12
Activities, NACEBEL
62010Computer programming, consultancy and related activities
62100Computer programming
58290Other software publishing
62900Other information technology and computer services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.